Concomitant overexpression of heat-shock protein 70 and HLA class-I in hepatitis C virus-related hepatocellular carcinoma

Anticancer Research

Volumn 29, Issue 2, 2009, Pages 539-544

  Yoshida, Shin ^a   Hazama, Shoichi ^a   Tokuno, Kazuhisa ^a   Sakamoto, Kazuhiko ^a   Takashima, Motonari ^a   Tamesa, Takao ^a   Torigoe, Toshihiko ^b   Sato, Noriyuki ^b   Oka, Masaaki ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; HLA class I; HSP70

Indexed keywords

HEAT SHOCK PROTEIN 70; HLA ANTIGEN CLASS 1;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER SURVIVAL; FEMALE; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; VIRUS CARCINOGENESIS;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPACIVIRUS; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 61449156585     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Zugel U and Kaufmann SH: Role of heat-shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 12: 19-39, 1999.
2. Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ and McGuire WL: Heat-shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst 85: 570-574, 1993.
3. Kaur J and Ralhan R: Differential expression of 70-kDa heat-shock protein in human oral tumorigenesis. Int J Cancer 63: 774-779, 1995.
4. Park CS, Joo IS, Song SY, Kim DS, Bae DS and Lee JH: An immunohistochemical analysis of heat-shock protein 70, p53, and estrogen receptor status in carcinoma of the uterine cervix. Gynecol Oncol 74: 53-60, 1999.
5. Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y and Foster C: Heat-shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 60: 7099-7105, 2000.
6. Malusecka E, Zborek A, Krzyzowska-Gruca S and Krawczyk Z: Expression of heat-shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study. Anticancer Res 21: 1015-1021, 2001.
7. Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, Asaka M and Hirohashi S: Expression profiling in multistage hepato-carcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 37: 198-207, 2003.
8. Castle PE, Ashfaq R, Ansari F and Muller CY: Immunohistochemical evaluation of heat-shock proteins in normal and preinvasive lesions of the cervix. Cancer Lett 229: 245-252, 2005.
9. Kurahashi T, Miyake H, Hara I and Fujisawa M: Expression of major heat-shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. J Urol 177: 757-761, 2007.
10. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Toda T, Sakaida I, Okita K, Oka M and Nakamura K: Proteomic profiling of heat-shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 3: 2487-2493, 2003.
11. Torigoe T, Asanuma H, Shimozawa K and Sato N: Immunohistochemical analysis of HLA class I expression in tumor tissues revealed unusually high frequency of down-regulation in breast cancer tissues. J Transl Med, in press.
12. Sobin LH and Wittekind C: TNM Classification of Malignant Tumours, 5th edition, International Union against Cancer. New York: John Wiley & Sons: pp. 74-77, 1997.
13. Yumoto Y, Hanafusa T, Hada H, Morita T, Ooguchi S, Shinji N, Mitani T, Hamaya K, Koide N and Tsuji T: Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroenterol Hepatol 10: 179-185, 1995.
14. Deng XL, Chen W, Cai MY and Wei DP: Expression of class I MHC molecule, HSP70 and TAP in human hepatocellular carcinoma. World J Gastroenterol 9: 1853-1855, 2003.
15. Fujiwara K, Higashi T, Nouso K, Nakatsukasa H, Kobayashi Y, Uemura M, Nakamura S, Sato S, Hanafusa T, Yumoto Y, Naito I and Shiratori Y: Decreased expression of B7 co-stimulatory molecules and major histocompatibility complex class-I in human hepato-cellular carcinoma. J Gastroenterol Hepatol 19: 1121-1127, 2004.
16. Joo M, Chi J G and Lee H: Expressions of HSP70 and HSP27 in hepatocellular carcinoma. J Korean Med Sci 20: 829-834, 2005.
17. Luk JM, Lam CT, Siu AF, Lam BY, Ng IO, Hu MY, Che CM and Fan ST: Proteomic profiling of hepatocellular carcinoma in a Chinese cohort reveals heat-shock protein (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 6: 1049-1057, 2006.
18. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Harada T, Fujimoto M, Sakaida I, Okita K, Oka M and Nakamura K: Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics 6: 3894-3900, 2006.
19. Li H, Sui C, Kong F, Zhang H, Liu J and Dong M: Expression of HSP70 and JNK-related proteins in human liver cancer: Potential effects on clinical outcome. Dig Liver Dis 39: 663-670, 2007.
20. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S and Hamamoto Y: Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 62: 3939-3944, 2002.
21. Garrido F and Algarra I: MHC antigens and tumor escape from immune surveillance. Adv Cancer Res 83: 117-158, 2001.
22. Franco A, Barnaba V, Natali P, Balsano C, Musca A and Balsano F: Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology 8: 449-454, 1988.
23. Paterson AC, Sciot R, Kew MC, Callea F, Dusheiko GM and Desmet VJ: HLA expression in human hepatocellular carcinoma. Br J Cancer 57: 369-373, 1988.
24. Sung CH, Hu CP, Hsu HC, Ng AK, Chou CK, Ting LP, Su TS, Han SH and Chang CM: Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma. J Clin Invest 83: 421-429, 1989.
25. Wadee AA, Paterson A, Coplan KA and Reddy SG: HLA expression in hepatocellular carcinoma cell lines. Clin Exp Immunol 97: 328-333, 1994.
26. Kurokohchi K, Carrington M, Mann DL, Simonis TB, Alexander-Miller MA, Feinstone SM, Akatsuka T and Berzofsky JA: Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma. Hepatology 23: 1181-1188, 1996.
27. Tatsumi T, Takehara T, Katayama K, Mochizuki K, Yamamoto M, Kanto T, Sasaki Y, Kasahara A and Hayashi N: Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma. Hepatology 25: 1108-1114, 1997.
28. Huang J, Cai MY and Wei DP: HLA class I expression in primary hepatocellular carcinoma. World J Gastroenterol 8: 654-657, 2002.
29. Chen W, Cai MY, Wei DP and Wang X: Pivotal molecules of MHC I pathway in human primary hepatocellular carcinoma. World J Gastroenterol 11: 3297-3299, 2005.
30. Tao J, Li Y, Liu YQ, Li L, Liu J, Shen X, Shen GX and Tu YT: Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors. Br J Dermatol 158: 88-94, 2008.
31. Kageshita T, Hirai S, Ono T, Hicklin DJ and Ferrone S: Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression. Am J Pathol 154: 745-754, 1999.
32. Watson NF, Ramage JM, Madjd Z, Spendlove I, Ellis IO, Scholefield JH and Durrant LG: Immunosurveillance is active in colorectal cancer as down-regulation but not complete loss of MHC class I expression correlates with a poor prognosis. Int J Cancer 118: 6-10, 2006.
33. Dressel R, Lubbers M, Walter L, Herr W and Gunther E: Enhanced susceptibility to cytotoxic T lymphocytes without increase of MHC class I antigen expression after conditional overexpression of heat-shock protein 70 in target cells. Eur J Immunol 29: 3925-3935, 1999.
34. Chen D and Androlewicz MJ: Heat-shock protein 70 moderately enhances peptide binding and transport by the transporter associated with antigen processing. Immunol Lett 75: 143-148, 2001.
35. Faure O, Graff-Dubois S, Alves PM, Cornet S, Duffour MT, Scardino A, Gross DA, Miconnet I, Salcedo M, Chouaib S, Lemonnier FA, Abastado JP and Kosmatopoulos K: Induction of multiple CDS+ T-cell responses against the inducible Hsp70 employing an Hsp70 oligoepitope peptide. Oncol Rep 17: 679-685, 2007.
36. Ikai I, Itai Y, Okita K, Omata M, Kojiro M, Kobayashi K, Nakanuma Y, Futagawa S, Makuuchi M and Yamaoka Y: Report of the 15th follow-up survey of primary liver cancer. Hepatol Res 28: 21-29, 2004.